A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma.
about
Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcomaWogonin suppresses stem cell-like traits of CD133 positive osteosarcoma cell via inhibiting matrix metallopeptidase-9 expressionMeta-analysis of the prognostic value of smad4 immunohistochemistry in various cancers.Glycolytic inhibitors 2-deoxyglucose and 3-bromopyruvate synergize with photodynamic therapy respectively to inhibit cell migration.Expression of matrix metalloproteinase-9, cyclooxygenase-2 and vascular endothelial growth factor are increased in gastrointestinal stromal tumors.Alkannin inhibits growth and invasion of glioma cells C6 through IQGAP/mTOR signal pathway.Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcomaNiclosamide suppresses migration of hepatocellular carcinoma cells and downregulates matrix metalloproteinase-9 expression.Distribution and activity levels of matrix metalloproteinase 2 and 9 in canine and feline osteosarcoma.By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasisNobiletin inhibits human osteosarcoma cells metastasis by blocking ERK and JNK-mediated MMPs expression.Immunohistochemical Markers as Predictors of Histopathologic Response and Prognosis in Rectal Cancer Treated with Preoperative Adjuvant Therapy: State of the Art.Significance of MTA1 in the molecular characterization of osteosarcoma.Comments on Li H et al. "A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma".Anti-Metastatic Properties of a Marine Bacterial Exopolysaccharide-Based Derivative Designed to Mimic Glycosaminoglycans.Shikonin inhibits invasiveness of osteosarcoma through MMP13 suppression.Knockdown of autophagy-related protein 6, Beclin-1, decreases cell growth, invasion, and metastasis and has a positive effect on chemotherapy-induced cytotoxicity in osteosarcoma cells.The prognostic value of pretreatment neutrophil-to-lymphocyte ratio in breast cancer: Deleterious or advantageous?The prognostic significance of serum and cerebrospinal fluid MMP-9, CCL2 and sVCAM-1 in leukemia CNS metastasis.Sirtuin 6 contributes to migration and invasion of osteosarcoma cells via the ERK1/2/MMP9 pathway.AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer.Beclin-1 knockdown decreases proliferation, invasion and migration of Ewing sarcoma SK-ES-1 cells via inhibition of MMP-9.Elevation of SHARPIN Protein Levels in Prostate Adenocarcinomas Promotes Metastasis and Impairs Patient Survivals.miR-30d inhibits cell biological progression of Ewing's sarcoma by suppressing the MEK/ERK and PI3K/Akt pathways in vitro.miR-145 suppresses the proliferation, invasion and migration of NSCLC cells by regulating the BAX/BCL-2 ratio and the caspase-3 cascade.Promoter hypermethylation of the cysteine protease RECK may cause metastasis of osteosarcoma.Hedgehog signalling in the tumourigenesis and metastasis of osteosarcoma, and its potential value in the clinical therapy of osteosarcoma.Validation of Neurotensin Receptor 1 as a Therapeutic Target for Gastric Cancer.Chalcone Derivatives 4'-Amino-1-Naphthyl-Chalcone (D14) and 4'-Amino-4-Methyl-1-Naphthyl-Chalcone (D15) Suppress Migration and Invasion of Osteosarcoma Cells Mediated by p53 Regulating EMT-Related Genes
P2860
Q28072875-9784600D-6ACC-4656-AF13-F176E914FF62Q32175594-678D7030-3ADB-4AF1-9E2B-62CB8A9E8D36Q34344060-9B4434B1-DFA8-4425-BEAE-65CA44B1A142Q35551013-BED19465-E53E-4240-B897-EE77926598E3Q35791583-AA835298-D7A7-41E2-B025-0096F078CFE2Q35791847-08609202-B434-4C09-84C5-587D826C6877Q35958404-6EEC4D3A-EB5E-4483-B698-33A3750AF7F0Q36335790-37EF3848-380F-4FC2-9443-8D719093E130Q36390133-5992A0EB-713F-446F-9AEB-72EEFF2EA0EDQ36413730-2B510673-4320-4BC0-9BB8-8C0BBC2400F7Q37376512-2AE4D281-9CB6-47FC-8664-BCC86B087A21Q37689910-4FED1DBA-8A13-42A3-ACCA-3E1D6DE3FA1FQ38260257-F4E5A59A-9FA9-4CCC-8484-A6FE7F9D6E3AQ38270462-CFAFAEA8-D51C-424F-8F34-C0BBA49C71C0Q38787678-C8E966B6-9991-4094-A286-D3EAAFAA6D0BQ38860724-073875F9-EBA3-4977-8E61-22ABCC1D242BQ38937531-BD781006-7E56-4365-9F88-B6A8DDB2A198Q39400399-37962334-5797-468C-B188-450D6646BA25Q41513151-E3B14381-4CF9-4E5B-BF8F-0F99ED586A03Q41627701-D48957B1-F45E-495E-97EC-175037A9B70CQ46132734-BC202956-DE7A-4B88-8DF0-7A96F234FE0CQ49971485-AF5EF4D6-37E3-4A6F-8EC5-D064299B99BAQ51125940-9DCB6DEC-E93C-41BA-A8F3-2C1BB95A015BQ52655155-D6DF0404-9C03-47BB-A393-0415CA396AF0Q52655160-FA4046A8-2FFD-430E-B24F-A556032FCC36Q53446053-24D17B31-8675-4D6E-B6F8-003BF4096166Q55105367-DD93D3B6-153C-4F64-B422-6BC5528FAF69Q55427672-ED7D9481-0F2D-4A5A-8840-E0D8A9F7276EQ58716411-D3A08659-1294-4292-B023-11081325C1C6
P2860
A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A systematic review of matrix ...... in patients with osteosarcoma.
@en
type
label
A systematic review of matrix ...... in patients with osteosarcoma.
@en
prefLabel
A systematic review of matrix ...... in patients with osteosarcoma.
@en
P2093
P2860
P1433
P1476
A systematic review of matrix ...... in patients with osteosarcoma.
@en
P2093
Hong-bin Guo
Li-hong Liu
Yurong Ouyang
P2860
P2888
P304
P356
10.1007/S13277-014-1717-3
P577
2014-02-28T00:00:00Z
P6179
1047757657